Auvelity registration europe poland?

Short answer: Auvelity is not registered in Europe, including Poland, as of my latest update. It is FDA-approved in the United States, but there is no EU marketing authorization for Auvelity yet.

What this means:
- There is no official EU or Polish marketing authorization for Auvelity at this time.
- To be sold in Poland (and other EU countries), a sponsor would need EMA authorization (centralized or national, depending on the filing) and then national marketing authorization in Poland.

How you can check current status:
- EU level: EMA’s Find a medicine database (emphasis: if Auvelity is listed there, it’s authorized in the EU).
- Poland: Polish regulatory database and URPL (Urząd Rejestracji Produktów Leczniczych) for any locally authorized drugs or updates.

If you’re a patient or clinician:
- For EU/Poland access, you’d need an EU-approved alternative for major depressive disorder.
- If you want, I can help you look up the latest status or provide steps to track regulatory updates.

Would you like me to check the very latest status or guide you on how to monitor updates from EMA and URPL?